Das ist der Job
This role requires a
Darum lohnt es sich
About Us Oruka Therapeutics (Nasdaq: ORKA) is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases.
Oruka’s mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice per year.
Oruka is advancing a proprietary portfolio of potentially best‑class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases.
For more information, visit Job Title Director, Clinical Monitoring Strategy and Optimization Location Remote or Waltham, MA or Menlo Park, CA, Hybrid – onsite up to 3 days/week is required when not traveling.
Role Overview We are seeking an experienced and highly motivated Director of Clinical Monitoring Strategy and Optimization to provide strategic and operational leadership for clinical monitoring activities across our development programs.
This individual will play a critical role in building and scaling clinical operations infrastructure within a fast‑paced emerging biotech environment.
The successful candidate will oversee CRO monitoring performance, ensure high‑quality execution of clinical trials, and contribute to the development of monitoring processes, vendor oversight strategies, and inspection readiness activities.
